Dosemeci M, Cocco P, Chow W H
Occupational Epidemiology Branch, National Cancer Institute, Bethesda, Maryland, USA.
Am J Ind Med. 1999 Jul;36(1):54-9. doi: 10.1002/(sici)1097-0274(199907)36:1<54::aid-ajim8>3.0.co;2-0.
Organic solvents have been associated with renal cell cancer; however, the risk by gender and type of solvents is nuclear.
We evaluated the risk of renal cell carcinoma among men and women exposed to all organic solvents-combined, all chlorinated aliphatic hydrocarbons (CAHC)-combined, and nine individual CAHC using a priori job exposure matrices developed by NCI in a population-based case-control study in Minnesota, U.S. We interviewed 438 renal cell cancer cases (273 men and 165 women) and 687 controls (462 men and 225 women).
Overall, 34% of male cases and 21% of female cases were exposed to organic solvents in general. The risk of renal cell carcinoma was significantly elevated among women exposed to all organic solvents combined (OR = 2.3; 95% CI = 1.3-4.2), to CAHC combined (OR = 2.1; 95% CI = 1.1-3.9), and to trichloroethylene (TCE) (OR = 2.0; 95% CI = 1.0-4.0). Among men, no significant excess risk was observed among men exposed to any of these nine individual CAHCs, all CAHCs-combined, or all organic solvents-combined.
These observed gender differences in risk of renal cell carcinoma in relation to exposure to organic solvents may be explained by chance based on small numbers, or by the differences in body fat content, metabolic activity, the rate of elimination of xenobiotics from the body, or by differences in the level of exposure between men and women, even though they have the same job title.
有机溶剂与肾细胞癌有关;然而,按性别和溶剂类型划分的风险尚不清楚。
在美国明尼苏达州一项基于人群的病例对照研究中,我们使用美国国立癌症研究所(NCI)开发的先验工作暴露矩阵,评估了接触所有有机溶剂、所有氯代脂肪烃(CAHC)以及九种单独的CAHC的男性和女性患肾细胞癌的风险。我们采访了438例肾细胞癌患者(273名男性和165名女性)和687名对照者(462名男性和225名女性)。
总体而言,34%的男性病例和21%的女性病例曾接触过有机溶剂。接触所有有机溶剂的女性患肾细胞癌的风险显著升高(OR = 2.3;95% CI = 1.3 - 4.2),接触CAHC的女性风险也显著升高(OR = 2.1;95% CI = 1.1 - 3.9),接触三氯乙烯(TCE)的女性风险同样显著升高(OR = 2.0;95% CI = 1.0 - 4.0)。在男性中,接触这九种单独的CAHC中的任何一种、所有CAHC或所有有机溶剂的男性均未观察到显著的额外风险。
观察到的有机溶剂暴露与肾细胞癌风险之间的性别差异,可能是由于样本量小而偶然出现的,也可能是由于身体脂肪含量差异、代谢活性差异、体内外源性物质消除速率差异,或者是由于男女之间暴露水平的差异,即使他们具有相同的工作头衔。